2025-04-10 - Analysis Report
## Robinhood Markets Inc (HOOD) Stock Review

This report analyzes Robinhood Markets Inc (HOOD), a commission-free brokerage offering a mobile-first investing platform.

**1) Performance Comparison & Divergence:**

HOOD's cumulative return (80.41%) significantly outperforms the S&P 500 (VOO) cumulative return (10.79%) over the analyzed period.  The difference is 69.6 percentage points.  This places HOOD at the 58th percentile of its historical divergence from the S&P 500 based on the provided range (max: 162.5, min: -58.6).


**Alpha & Beta Analysis:**

The provided CAGR, MDD, Alpha, Beta, and market capitalization data show significant volatility and varying performance across different periods.  While recent periods (2022-2025) show high CAGR and positive Alpha, the 2021-2023 period demonstrates negative CAGR. The high Beta consistently indicates significant sensitivity to market movements.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | -9.0% | 72.8% | -23.0% | 11.3 |
| 2022-2024  | 151.0% | 74.3% | 128.0% | 33.0 |
| 2023-2025  | 124.0% | 81.0% | 112.0% | 37.4 |


**2) Recent Price Movement:**

HOOD's closing price is $42.21.  Recent price movements show the stock trading above its 5-day and 20-day moving averages but below its 60-day moving average, suggesting potential short-term support but possibly facing resistance at higher levels.  The significant price jump from the previous close (+$8.04 or 23.53%) indicates a recent sharp upward movement.

* Closing Price: $42.21
* 5-Day MA: $36.91
* 20-Day MA: $41.32
* 60-Day MA: $47.29


**3) Technical Indicators & Expected Return:**

The Market Risk Indicator (MRI) of 0.5289 suggests a high-risk level for HOOD.  The RSI (47.65) is near the neutral level (50), indicating neither overbought nor oversold conditions.  A negative PPO (-0.76) suggests bearish momentum. The recent (20-day) relative divergence change of -11.7% indicates a recent downward trend. The large positive price change in `Last-market` (23.53%) suggests a recent sharp price increase.  The expected return of -20.1% suggests a negative outlook, contrasting sharply with the historical high cumulative return.  Long-term (2+ years) accumulation investment could potentially outperform the S&P 500, despite the negative expected return.  More data and context are required to assess long term performance reliably.


**4) Recent Earnings Analysis:**

HOOD has consistently exceeded EPS expectations in recent quarters, demonstrating positive earnings surprises.

| Date       | EPS    | Expected EPS |
|------------|--------|--------------|
| 2025-02-12 | 0.54   | 0.4184       |
| 2024-10-30 | 0.17   | 0.18         |
| 2024-08-07 | 0.21   | 0.15         |
| 2024-05-08 | 0.18   | 0.06         |
| 2024-02-13 | 0.03   | 0.0074       |


**5) Financial Information:**

Revenue growth shows a positive trend, although growth has somewhat slowed recently. Profit margins are consistently high, indicating strong profitability.  Equity is also increasing, though ROE fluctuates, suggesting variable profitability in some periods.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $1.01B   | 85.80%        |
| 2024-09-30 | $0.64B   | 81.00%        |
| 2024-06-30 | $0.68B   | 81.96%        |
| 2024-03-31 | $0.62B   | 81.23%        |
| 2023-12-31 | $0.47B   | 78.13%        |

**Capital and Profitability:**

| Quarter     | Equity   | ROE    |
|-------------|----------|--------|
| 2024-12-31 | $7.97B   | 11.49% |
| 2024-09-30 | $7.21B   | 2.08%  |
| 2024-06-30 | $7.12B   | 2.64%  |
| 2024-03-31 | $6.88B   | 2.28%  |
| 2023-12-31 | $6.70B   | 0.45%  |


**6) Overall Analysis:**

HOOD exhibits high growth potential but also significant volatility. While recent earnings have been positive and exceeding expectations, the high beta and negative expected return signal caution. The substantial outperformance relative to the S&P 500 is notable, but the sustainability of this divergence remains uncertain.  Investors should carefully consider the high-risk profile indicated by the MRI and the significant price swings before making any investment decisions. Further analysis, including a deeper dive into the company's fundamentals and competitive landscape, is recommended.  The recent sharp price increase warrants close monitoring for potential correction.
